Imaging the heart to test new medicines after a heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This study uses special heart and blood vessel imaging to see how two new medicines affect inflammation and healing after a heart attack. It is an early-stage trial that may help doctors improve recovery after a heart attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have recently had a type 1 heart attack (the most common kind, caused by a blocked artery).
- You had or will have a procedure to open the blocked artery (like an angioplasty or stent) within the last 48 hours.
- You need to have plaque in your neck or leg arteries, or a thicker-than-usual artery lining in your neck (more than 1.5 mm).
- You cannot have severe heart failure, very irregular heartbeats, or a major complication from the heart attack (like a tear in the heart muscle).
- You cannot have active cancer, a recent stroke (within 3 months), or serious kidney problems (GFR less than 30).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
This trial looks at how to assess small blood-vessel (microvascular) problems in people who had a heart attack but whose main heart arteries are not blocked. It may help doctors better find what’s driving symptoms and choose the right tests and treatments.
This study looks at how immune cells change in the first few hours after a severe heart attack (STEMI) and how that relates to early scar healing. It may help doctors understand why some patients heal better than others.
This trial compares two ways to guide treatment during a heart attack: using a special camera (OCT) inside the artery or standard X-ray (angiography). It aims to see which method leads to better results for patients.
This study tests a new imaging agent that highlights inflammation in the heart after a heart attack. It may help doctors see how much damage occurred and guide treatment.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Hear when a new Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.